APL-9 / Apellis  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
APL-9 / Apellis
NCT04402060: A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19

Completed
1/2
72
US, RoW
APL-9, Vehicle Control
Apellis Pharmaceuticals, Inc.
COVID, Covid-19, Coronavirus, Coronavirus Infection, Severe Acute Respiratory Syndrome, Severe Acute Respiratory Syndrome Coronavirus 2, Sars-CoV2, Ards, Acute Respiratory Distress Syndrome
02/21
02/21

Download Options